ClinicalTrials.gov
public full text
Public Domain
Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
The purpose of this study was to evaluate the safety and efficacy of afamelanotide (previously developed as CUV1647) as adjunctive therapy in patients undergoing photodynamic therapy using porfimer sodium.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose Parameters for Photodynamic Therapy on Periodontal Disease#174908
- Focused ultrasound-mediated sonochemical internalization: an alternative to light-based therapies#1328484
- Comparative Analysis of Photodynamic Therapy on Periapical Healing#844518
- Antimicrobial Photodynamic Therapy in the Nasal Decolonization of Maintenance Hemodialysis Patients#291013
- Photodynamic Therapy for the Treatment of COVID-19#1057140
Record · ID 1418537
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive